جست‌وجوی استاد و پژوهشگر

• Neural Interfaces
• Micro/Nano Electro Mechanical Systems (MEMS)
• Biosystems & Computational Biology
• +۳ مورد دیگر

Michel M. Maharbiz is a Professor in the Department of Electrical Engineering and Computer Science at the University of California, Berkeley. He leads research on miniaturized bioelectronic interfaces, including neural dust implants and cyborg insects. He holds affiliations with the Berkeley Sensor & Actuator Center (BSAC), Center for Neural Engineering & Prostheses (CNEP), and SWARM Lab. His education includes a Ph.D. in EECS from UC Berkeley (2003) and a B.S. in EE from Cornell University (1997). Maharbiz's research integrates MEMS, ultrasonic systems, and synthetic biology to develop wireless neural interfaces, implantable sensors, and biohybrid devices. Key focus areas are neural dust technology for peripheral nerve recording, magnetoelastic strain sensors for medical applications, and electrochemical biosensing using bacterial flagellar motors. His publications emphasize neural interfaces, ultrasonic implants, and biomedical monitoring. Recent articles explore ultrasonic power delivery (2025), radiation detectors for oncology (2025), and fracture-healing smart plates (2019). Trends include miniaturization of wireless implants, closed-loop therapeutic systems, and novel biomaterials. Scientific Awards: McKnight Technological Innovations in Neuroscience Award (2017) Chan-Zuckerberg Biohub Investigator (2017) NSF CAREER Award (2009) MIT TR10 Top Emerging Technology (2009) Bakar Fellows Spark Award (2012) He directs the Maharbiz Lab, advancing neural dust and bioelectronic interfaces. Projects include impedance-based fracture monitoring, carbon fiber neural arrays, and hernia repair sensors. Funding includes NSF and industry partnerships for implantable device development.

Matthew L Beckerمشاهده پروفایل

استاد

• Polymer chemistry
• Bioconjugate chemistry
• Molecular imaging
• +۵ مورد دیگر

Matthew L Becker is the Hugo L Blomquist Distinguished Professor of Chemistry at Duke University, with additional appointments in Mechanical Engineering and Material Science, and Biomedical Engineering. His research focuses on polymer chemistry, bioconjugate chemistry, molecular imaging, additive manufacturing, and degradable materials for bone, soft tissue, neural, and vascular tissue engineering. Education: B.S. from Northwest Missouri State University (1998), M.A. (2000) and Ph.D. (2003) from Washington University in St. Louis Research interests include developing tunable degradable polymers for flexible electronics, tissue engineering (bone, neural, vascular), and additive manufacturing. His group is pioneering 3D printing of bioresorbable medical devices and custom inks for biomaterials. Recent work explores stereochemistry-dependent polymer properties, mechanochromism, and machine learning-driven biomaterials design. Key applications: Drug delivery systems Biodegradable adhesives Tissue regeneration scaffolds Scientific honors include: Fellow, National Academy of Inventors (2022) Fellow, American Chemical Society (2020) Carl S. Marvel Award in Creative Polymer Chemistry (2019) Fellow, American Institute for Medical and Biomedical Engineering (2018) Fellow, Royal Society of Chemistry (2017) Biomacromolecules/Macromolecules Young Investigator Award (2015) He teaches advanced courses in mechanical engineering and polymer chemistry, with a focus on 3D printing and biomaterials. His group has developed novel medical devices including resorbable suture anchors, hernia mesh coatings, and neuroprosthetic scaffolds.

• Bioengineering
• Tissue Engineering
• Regenerative Medicine
• +۴ مورد دیگر

Houman Savoji is an Associate Professor in the Department of Pharmacology and Physiology at the Faculty of Medicine, University of Montreal. He is also a full-time researcher at the CHU Sainte-Justine Research Center and principal investigator in regenerative medicine, organs-on-chip, and bioprinting at TransMedTech Institute. Dr. Savoji received his PhD in Biomedical Engineering from the Institute of Biomedical Engineering at Polytechnique Montréal in 2016. He then completed a postdoctoral fellowship at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. His research expertise combines advanced manufacturing technologies (micro- and nano-fabrication, 3D bioprinting, microfluidics, cell electrospinning) with functional and composite materials for applications in tissue engineering, regenerative medicine, and organs-on-chip. His work focuses on the design, development, optimization, implementation, and characterization of innovative functional biomaterials using emerging engineering technologies, with particular emphasis on cardiac tissue engineering and biomimetic pulmonary heart valves for pediatric patients. Dr. Savoji has published extensively on biomaterials, tissue engineering, 3D bioprinting, and organ-on-chip technologies. His recent publications demonstrate expertise in viscoelastic characterization of soft tissues, engineering immune responses to biomaterials, ceramic engineering for biomedical applications, and advanced 3D bioprinting techniques for cardiac and vascular tissue engineering. 2017-2020, Postdoctoral Research Grant, CIHR 2017-2019, Postdoctoral Research Grant, FRQNT 2017-2018, Human Society of International Grant, Human Toxicity Assessment Project 2016, CR-CHUM Research Center Award 2015, Star Student-Researcher Award, FRQNT 2014-2015, Jane and Frank Warchol Fellowship, Society of Vacuum Coaters Foundation 2013, Institute of Textile Science Award 2012-2015, Excellence Doctoral Scholarship for Foreign Students, FRQNT Dr. Savoji has supervised Master's students including Ines Barrakad (2024) working on 'Advanced manufacturing technologies versus molding of corneal implants: 3D printing vs molding of a Keratoprosthesis' and Zineb Ajji (2023) researching 'Development of perfusable patches by 3D bioprinting for potential application in cardiac tissue regeneration.' He has secured numerous research grants from organizations including CIHR, NSERC, FRQNT, FRQS, MITACS, and others for projects related to 3D bioprinting of cardiac tissues, biomimetic heart valves, and other tissue engineering applications. The Savoji Laboratory, located within the Department of Pharmacology and Physiology and Institute of Biomedical Engineering of the Faculty of Medicine of the University of Montreal, the Research Center of the CHU Sainte-Justine (CHUSJ), and the TransMedTech Institute, focuses on multidisciplinary research involving 3D bioprinting using stem-cell derived human cardiac cells to fabricate functional cardiac tissues for transplantation and drug discovery applications.

• Sports Medicine
• Orthopaedic Surgery
• Anterior Cruciate Ligament (ACL) Injuries
• +۷ مورد دیگر

Dr. Christina Allen is a Professor of Orthopaedics & Rehabilitation at Yale School of Medicine, where she serves as Chief of Yale Sports Medicine and Vice Chair of Athletic Medicine and Community Outreach. She is the Orthopaedic Team Physician for Yale Athletics and has extensive experience with U.S. national teams, including U.S. Soccer and USA Taekwondo. Education: BS in Biomedical Engineering, Duke University (1983); MD, UCLA School of Medicine (1995) Training: Orthopaedic Residency and Sports Medicine Fellowship, University of Pittsburgh Research Interests focus on: Revision ACL reconstruction outcomes and predictors Meniscus transplantation and cartilage repair Proximal hamstring avulsion repair Quantitative MRI for joint kinematics and cartilage changes Post-ACL revision infection risk factors Scientific Awards include: Kappa Delta Ann Doner Vaughn Award (2019) NIH R01 Competitive Renewal Grant (2017) AOSSM O’Donoghue Award (2014) Clinical Roles span: Team physician for U.S. Soccer (Women's/Men's National Teams) Former team physician for San Francisco Deltas (NASL Champions 2017) Medical Board member, World Taekwondo (London Olympics 2012, Rio Olympics 2016) Publications highlight a 20-year longitudinal focus on: Machine learning models for surgical outcome prediction Graft choice impact on revision ACL longevity Cartilage degeneration after meniscectomy Biomechanical MRI analysis of joint kinematics Infection rates in revision surgeries Return-to-sport protocols for athletes

• Stem Cell Mechanobiology
• Bone Tissue Engineering
• Regenerative Medicine
• +۳ مورد دیگر

Chao Liu is an Associate Professor at the Department of Biomedical Engineering , Southern University of Science and Technology (2024.11–present). Previously, he served as an Assistant Professor at the same institution (2019–2024.11) and completed a Postdoctoral Fellowship at New York University (2016–2019) with joint appointments in the Department of Biomedical Engineering and Orthopedics at NYU Langone Health . He holds a PhD in Biomedical Engineering (2016) and MASc in Mechanical Engineering (2010) from University of Toronto , following a BASc in Engineering Science (2008). Education : PhD (IBBME, U of Toronto, 2016), MASc (Mechanical Engineering, U of Toronto, 2010), BASc (Engineering Science, U of Toronto, 2008) His research focuses on mechanobiology of stem cells , bone tissue engineering , and functional implants . He investigates how mechanical forces modulate osteogenic and angiogenic stem cells, designs implants with micro-geometry to enhance cellular activity, and develops 3D real-time imaging modalities for bone repair processes. His work spans biomechanics , regenerative medicine , and cellular mechanotransduction . The selected publications from 2022 to 2010 reveal trends in mechanical force applications for bone regeneration, pharmacological impairments in healing, nanostructured biomaterials for stem cell differentiation, and microfluidic platforms for osteocyte studies. These works are published in journals like Bone , FASEB Journal , and ACS Applied Materials & Interfaces . Scientific Awards : International Conference BME Young Investigator Award (2019), IFMRS Travel Grant (2017), ASBMR Young Investigator Grant (2016), CIHR Travel Awards (2010–2014), Ontario Graduate Scholarship (2011–2013), Barbara and Frank Milligan Fellowship (2008, 2010) Chao Liu mentors graduate students, including Zhang Jianing (2022 Master’s graduate). His lab ( https://abtrl.bme.sustech.edu.cn/ ) recruits postdocs and research assistants for projects in mechanical force applications , micro-geometric implants , and 3D imaging . He has contributed to 14 journal articles with 714 citations and presented at 6 international conferences in the past three years.

• Stem Cell Biology
• Genetic Engineering
• Epigenetics
• +۵ مورد دیگر

Konstantinos Anastassiadis is a Professor at the Center for Molecular and Cellular Bioengineering (CMCB) of Dresden University of Technology , leading the Stem Cell Engineering group at the Biotechnology Center (BIOTEC) . His research focuses on unraveling molecular pathways regulating stem cell self-renewal and lineage commitment, with a strong emphasis on genetic engineering tool development and epigenetic mechanisms during cellular reprogramming. The lab utilizes mouse and human embryonic stem cells, neural stem cells, mesenchymal stromal cells, and induced pluripotent stem cells (iPSCs) in their investigations. Core Research Areas: Molecular regulation of stem cell fate Epigenetic mechanisms (e.g., UTX/UTY histone demethylases) Genetic engineering tool development (Flp, Dre, Vika recombinases, CRISPR protocols) Conditional immortalization systems for rare cell expansion Publications highlight his contributions to understanding: Role of histone methyltransferases (MLL1, MLL2, Setd1b) in hematopoiesis and cancer Epigenetic regulation during mouse development and spermatogenesis Genetic tools for protein tagging, transposon-mediated BAC transgenesis Interactions between stem cells and niche microenvironments Transcriptional and mechanical markers during reprogramming Collaborations span immunology , developmental biology , and bioinformatics . The lab actively participates in teaching activities at CMCB and maintains a focus on translational applications of stem cell research.

Yayue Panمشاهده پروفایل

استاد

• Additive Manufacturing
• Multi-Material Additive Manufacturing
• Biomedical Additive Manufacturing
• +۴ مورد دیگر

Yayue Pan is a Professor at the Department of Mechanical and Industrial Engineering, University of Illinois Chicago (UIC) , and serves as the Director of NASA MIRO Center for In-Space Manufacturing: Recycling and Regolith Processing (CISM-R2) . Her research focuses on advancing Additive Manufacturing (AM) technologies for applications in biomedical engineering , energy storage , and smart structures . Ph.D., Industrial and Systems Engineering, University of Southern California (2014) M.S., Mechanical Manufacturing and Automation, Zhejiang University, China (2010) B.S., Industrial Engineering, Zhejiang University of Technology, China (2007) Her work addresses technical challenges in AM such as multi-material printing , multi-scale fabrication , and field-assisted processes . Notable projects include: Development of electrostatically-assisted direct ink writing (eDIW) for high-speed, high-resolution printing Continuous projection stereolithography for rapid solid object manufacturing Acoustic field-assisted particle patterning for smart composites Light-curable hydrogels for corneal repair applications Her 15 most recent publications (2022–2025) span topics in: Multi-material AM (conductive polymers, hierarchical composites) Biomedical applications (soft robotics, corneal repair) Energy components (battery electrolytes, supercapacitors) Field-assisted processes (acoustic, electrostatic, magnetic) Scientific Awards : 2024 ASME Chao and Trigger Young Manufacturing Engineer Award 2022 UIC Researcher of the Year Rising Star Award 2020 ASME CIE TC Leadership Award 2019 UIC Outstanding Teaching Award 2017 SME Outstanding Young Manufacturing Engineer Award NSF REU Supplements (2023–2024) Advising : Mentored 24+ graduate/undergraduate researchers, including 17 NASA/GPIP interns. Former advisees hold academic positions at University at Buffalo and University of North Carolina at Charlotte , and industry roles at Apple , GE Healthcare , and ANSYS . Grants : Recipient of a $4.65M NASA grant and multiple NSF awards. Collaborations include Northwestern University, University of Michigan, and NASA centers.

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +۱۲ مورد دیگر

Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.

• Sports Medicine
• Physiology
• Sports Injury
• +۴ مورد دیگر

Michael Kjær is a Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, Faculty of Health and Medical Sciences. He specializes in Internal Medicine: Rheumatology and leads research groups focused on exercise physiology, sports injuries, and aging. His work addresses the impact of physical activity on the human organism, with particular emphasis on tissue damage and repair mechanisms. Dr. Kjær's primary research interests center around sports medicine, physiology, and exercise science. His work investigates tendon pathology, muscle physiology, sports injuries, and the effects of exercise on aging populations. He has made significant contributions to understanding sports-related injuries, particularly tendon overuse conditions, and the physiological responses to physical activity across different age groups. His recent publications (2025) demonstrate a strong focus on tendon research, sports injury treatment dilemmas, effects of anabolic steroid abuse, muscle physiology, and bone health in athletes and older adults. The research spans from basic science investigations of cellular mechanisms to clinical studies addressing practical sports medicine challenges. His work shows particular strength in connecting molecular and tissue-level changes with clinical outcomes in sports medicine. With 415 research outputs including 369 journal articles, 15 book chapters, and 15 reviews, Dr. Kjær maintains an active research program with substantial impact. His work has been referenced in Wikipedia pages, cited by Bluesky users, and picked up by news outlets, demonstrating its relevance to both academic and public discourse. Dr. Kjær leads multiple research groups within the Center for Healthy Aging Damage and Repair at the Department of Clinical Medicine. His laboratory work focuses on tissue response to injury and exercise, particularly examining tendon and muscle physiology using both in vivo and in vitro approaches. His research bridges basic science with clinical applications in sports medicine and rehabilitation.

Foteini Mourkiotiمشاهده پروفایل

دانشیار

• Muscle Stem Cell Biology
• Mechanobiology
• Aging
• +۷ مورد دیگر

Foteini Mourkioti is an Associate Professor at the University of Pennsylvania's Perelman School of Medicine , with a joint appointment in the Graduate Groups of Cell and Molecular Biology and Bioengineering . She co-directs the Musculoskeletal Regeneration Program at the Penn Institute of Regenerative Medicine and leads the McKay Orthopaedic Research Laboratory . Research Interests : Muscle Stem Cell Biology Mechanobiology Muscle Regeneration Telomere Biology in Muscular Diseases Fibrodysplasia Ossificans Progressiva (FOP) Cardiomyopathy and Aging Key Research Contributions : Developed the Pax7EGFP mouse model for real-time muscle stem cell tracking Discovered telomere shortening as a critical factor in Duchenne Muscular Dystrophy Elucidated the role of NF-κB in muscle stem cell dysfunction Identified Piezo1's role in stem cell morphological states Characterized fibro-adipogenic progenitor dynamics in FOP Scientific Awards : NIH/NHLBI R01 grant recipient (2019) NASA grant awardee (2020, 2017) American Heart Association grant (2017) Muscular Dystrophy Association grant (2019) University Research Foundation grant (2018) Publications & Collaborations : Over 25 publications in high-impact journals like Science Advances , Nature Protocols , and Cell Reports . Collaborates with Penn Cardiovascular Institute and Pennsylvania Muscle Institute.

Maria Timofeevaمشاهده پروفایل

دانشیار

• Cancer Epidemiology
• Genetic Risk Factors
• Colorectal Cancer
• +۷ مورد دیگر

Maria Timofeeva is an Associate Professor in the Epidemiology, Biostatistics and Biodemography (EBB) department at the University of Southern Denmark (SDU), with additional affiliation at the Danish Institute for Advanced Study (DIAS). She holds an Honorary Fellow position at the University of Edinburgh since December 2019. Her research focuses on cancer prevention and prediction, particularly studying the effects of environmental and genetic factors on cancer risk and progression. Dr. Timofeeva earned her Dr.sc.hum in Epidemiology from Heidelberg University (2005-2009), with a dissertation on genetic polymorphisms as risk factors for early onset lung cancer. Prior to her current position, she worked as a Statistical Geneticist at the University of Edinburgh (2013-2019) and as a Postdoctoral Fellow at the International Agency for Research on Cancer (2009-2013). Her research interests center around understanding the genetics of cancer risk through multi-omic analysis. She leads several significant projects, including the Interdisciplinary Project on Adherence to Colorectal Cancer Screening, meta-analysis of factors associated with false-positive and false-negative FOBT results (registered in PROSPERO ID: CRD42022315767), and the COlorectal Cancer screening Among RElatives (CoCARE) twin-family study in Denmark. Her methodological expertise spans observational epidemiological studies (case-control, population-based cohort studies, twin studies), meta-analysis, umbrella reviews, and multi-omics data analysis. Analysis of her recent publications reveals a strong focus on colorectal cancer genetics, with particular emphasis on genome-wide association studies, Mendelian randomization approaches, and trans-ancestry analyses. Her work frequently leverages large datasets including the UK Biobank and international consortia, with applications in cancer risk prediction and understanding gene-environment interactions. Dr. Timofeeva has an extensive publication record with 73 publications listed in her profile. Her research has been cited across multiple platforms, with mentions in news outlets, social media, and academic readership platforms like Mendeley. She is actively involved in academic service, serving as a peer reviewer for journals including BMC Cancer and Scientific Reports, and participating in conferences such as the 26th Nordic Congress of Gerontology. She also serves on evaluation committees, including with the World Cancer Research Fund International (April-May 2024). Her teaching activities include courses on evidence-based drug utilization and biostatistics, as well as supervision of research projects on gene expression in twins. Dr. Timofeeva has engaged with the public through media contributions, including an interview titled 'Jeg vil forstå, hvorfor vi får kræft' (November 15, 2021), where she discussed understanding why we get cancer.

Caetano Reis e Sousaمشاهده پروفایل

استاد

• Immunology
• Infectious Disease
• Cancer Immunotherapy
• +۳ مورد دیگر

Caetano Reis e Sousa is a Professor of Immunology at Imperial College London and Senior Group Leader/Assistant Research Director at the Francis Crick Institute. He leads the Immunobiology Laboratory, focusing on dendritic cell biology, immune responses to pathogens, and cancer immunotherapy. His research explores how dendritic cells detect pathogens and dying cells, triggering adaptive immunity. Key roles include investigating cross-presentation mechanisms, C-type lectin receptors (e.g., DNGR-1), and vaccine development strategies. Education: BSc (Hons) Biology from Imperial College London (1989), DPhil in Immunology from University of Oxford (1992). Postdoctoral training at NIH under Ron Germain. Career milestones include founding the Immunobiology Lab at CRUK London Research Institute (1998–2015) before joining the Crick. Awards & Recognition: Highly Cited Researcher (Thomson Reuters), BD Biosciences Prize (2002), Liliane Bettencourt Award (2008), Louis-Jeantet Prize (2017), Fellowships at Royal Society (2019), Academy of Medical Sciences (2006), and EMBO (2006). Named Officer of the Order of Sant'Iago da Espada (Portugal, 2009). Research Themes: Dendritic cell activation pathways, cross-presentation of tumor antigens, microbiome-cancer immunity links, and immune evasion mechanisms. Collaborations involve institutions like UCL, King's College London, and global health networks. Labs/Teams: Head of Immunobiology Lab at Crick, with expertise in immunology, cell biology, and virology. Facilities include Flow Cytometry, Genomics, and Light Microscopy cores. Active in pandemic response (e.g., SARS-CoV-2 testing initiatives).

Darryl Dickersonمشاهده پروفایل

استادیار

• Biomedical Engineering
• Mechanical Characterization of Biological Interfaces
• Bioinspired Materials Design
• +۴ مورد دیگر

Dr. Darryl Dickerson is an Assistant Professor in the Department of Mechanical and Materials Engineering at Florida International University (FIU), part of the College of Engineering. His research focuses on mechanical characterization of biological interfaces, design of bioinspired materials, and advancing inclusive engineering education practices. He holds a Ph.D. (details not explicitly provided in text). Research Interests: Dr. Dickerson’s work bridges biomechanics and biomaterials engineering with social equity in education. Key areas include: Mechanical properties of biological interfaces (e.g., bone-cartilage junctions) Development of biomaterials for tissue repair using 3D printing and electrospinning Anti-marginalization strategies in engineering education, particularly for Black and Brown students Publications Trends: Recent work emphasizes dual themes: (1) Biomedical innovation through advanced material fabrication and (2) Inclusive pedagogy addressing systemic inequities in STEM education. Notable contributions include scaffold designs for osteochondral repair and frameworks for reducing microaggressions in team-based learning. Grants and Advising: No specific grants or advisees listed in the provided text. His work appears to be grant-funded through NIH/National Science Foundation pathways common in biomaterials and education research. Labs and Teams: While not explicitly stated, his research likely involves collaborations with FIU’s Center for Engineering and Computing’s diversity initiatives and biomaterials labs focusing on tissue engineering applications.

• Mechanobiology
• Biomechanics
• Organ-on-chip
• +۵ مورد دیگر

Associate Professor Arnold Lining Ju is a biomedical engineer at the University of Sydney's School of Biomedical Engineering, affiliated with multiple institutes including the Heart Research Institute and Sydney Nano Institute. He holds academic positions in both the Faculty of Engineering and Faculty of Medicine & Health. Education: BSc from Peking University, PhD from Georgia Tech and Emory University (USA). Honors include Snow Fellowship, Heart Foundation Future Leader Fellowship, and multiple awards for cardiovascular research innovation. Research focuses on mechanobiology and biomechanics of thrombosis, developing microfluidic devices and organ-on-chip systems. Key projects include AI-driven single-cell nanotools, 3D biofabrication, and anti-thrombotic peptide design. Leads interdisciplinary teams and collaborates internationally with institutions like Harvard and University of Texas. Teaching roles include coordinating advanced cellular biomechanics courses and supervising PhD/Masters students in biomedical engineering and physiology. Over 50 peer-reviewed publications, with contributions to Nature Materials, Nature Communications, and other top journals.

Theresa Raimondoمشاهده پروفایل

استادیار

• Biomaterials
• Drug Delivery
• RNA-based Therapeutics
• +۵ مورد دیگر

Theresa Raimondo is the Manning Assistant Professor of Engineering at Brown University, with a secondary appointment in the Division of Biology and Medicine. She joined the Brown Engineering faculty in January 2024 after completing her postdoctoral training at MIT's Koch Institute. Dr. Raimondo leads the Raimondo Research Lab, which focuses on chemically modifying RNA and designing nanoparticles for therapeutic delivery to the body, an immunotherapy concept that holds immense promise in the field of immunoengineering. Her educational background includes: PhD in Engineering Sciences – Bioengineering from Harvard University (2019) MEng from Harvard University (2019) Sc.B. in Chemical and Biochemical Engineering from Brown University (2011) Dr. Raimondo's research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her work primarily centers on developing novel lipid nanoparticles (LNPs) for RNA-based therapies, contributing to adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By optimizing LNP formulation and modulating RNA constructs, she seeks to understand how RNA-LNPs modulate immunity and develop new therapeutic approaches. Her expertise spans biomaterials, drug delivery, biomolecular engineering, nanomedicine, tissue engineering, and regenerative medicine. Analysis of Dr. Raimondo's recent publications reveals a strong focus on RNA delivery systems and lipid nanoparticle technology. Her work spans from fundamental studies on nanoparticle design to applications in cancer immunotherapy, vaccine development, and tissue regeneration. A significant portion of her research involves optimizing lipid formulations for improved mRNA delivery and exploring how these systems interact with the immune system. Her publications demonstrate a trajectory from basic biomaterials research to increasingly translational work with therapeutic applications. Dr. Raimondo has received numerous prestigious awards: 2025 NAE Symposium selection (Grainger Foundation Frontiers of Engineering) 2025 appointment to the inaugural Early Career Board of ACS Applied Bio Materials 2024 selection as MIT Faculty Founder Initiative finalist 2022 Convergence Scholar fellowship from MIT's Marble Center for Cancer Nanomedicine National Science Foundation graduate research fellowship Harvard's Smith family graduate fellowship Dr. Raimondo is actively involved in mentoring students through courses including ENGN 0931L - Biomedical Engineering Design and Innovation II, ENGN 1490 - Biomaterials, and ENGN 1931L - Biomedical Engineering Design and Innovation II. Her research program is supported by various grants, though specific funding sources aren't detailed in the provided text. The Raimondo Research Lab represents a dynamic environment where engineering principles are applied to solve complex biological challenges in drug delivery and regenerative medicine. The Raimondo Research Lab at Brown University serves as a hub for innovation in RNA delivery and biomaterials design. The lab brings together expertise in chemical engineering, molecular biology, and immunology to develop next-generation therapeutic platforms. Current research directions include optimizing lipid nanoparticle formulations, exploring novel RNA modifications, and investigating immune responses to RNA therapeutics across various disease contexts.